The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
about
Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activityStructural and phylogenetic characterization of human SLURP-1, the first secreted mammalian member of the Ly-6/uPAR protein superfamilySoluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of ViewVEGF-initiated angiogenesis and the uPA/uPAR systemA plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiationPlasminogen activators direct reorganization of the liver lobule after acute injuryModulation of the Ca2+ conductance of nicotinic acetylcholine receptors by Lypd6.Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion.A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons.Mouse stem cell antigen Sca-2 is a member of the Ly-6 family of cell surface proteinsMimicry of the regulatory role of urokinase in lamellipodia formation by introduction of a non-native interdomain disulfide bond in its receptor.High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.Epitope-mapped monoclonal antibodies as tools for functional and morphological analyses of the human urokinase receptor in tumor tissueTherapeutic application of natural inhibitors against snake venom phospholipase A(2).Transgenic mice demonstrate novel promoter regions for tissue-specific expression of the urokinase receptor gene.Polymorphisms in Ly6 genes in Msq1 encoding susceptibility to mouse adenovirus type 1Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.Upregulation of urokinase receptor expression on migrating endothelial cells.Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.Mannose 6-phosphate receptor targeting and its applications in human diseases.Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.Generation and characterization of urokinase receptor-deficient mice.Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.Genome-wide protein QTL mapping identifies human plasma kallikrein as a post-translational regulator of serum uPAR levels.Primary focal and segmental glomerulosclerosis and soluble factor urokinase-type plasminogen activator receptorA composite role of vitronectin and urokinase in the modulation of cell morphology upon expression of the urokinase receptor.Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions.Targeted disruption of the K-ras oncogene in an invasive colon cancer cell line down-regulates urokinase receptor expression and plasminogen-dependent proteolysis.Proteolytic cleavage of the urokinase receptor substitutes for the agonist-induced chemotactic effectUrokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells.Transcriptional and post-transcriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumour promoters in the human lung carcinoma cell line A549.Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract.Two phospholipase A2 inhibitors from the plasma of Cerrophidion (Bothrops) godmani which selectively inhibit two different group-II phospholipase A2 myotoxins from its own venom: isolation, molecular cloning and biological properties.Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor.
P2860
Q24633333-FEE2596E-AB9C-45E8-8E84-73C72D1A723BQ24672686-864D1ACE-9543-4CB6-B272-4C17B73B01F6Q26738374-2A2811CD-4022-44F3-8308-E5E723D1FFAEQ27025897-CE61C4FB-DBF9-4D5C-B40B-E23C67547FC0Q28357136-9CBC9ABC-2E78-44DA-B4DF-8862A835A3EDQ28359705-EC7BCC55-9B09-4F1E-B8B1-737029D334E3Q28591810-24AD8CD6-AF17-44BA-947B-719E31F79888Q33709060-D4FC285B-5230-4466-BCD0-922B51E454B7Q33887878-91729B12-F677-429E-8C34-12C23948678FQ33907027-EA6663E6-6F84-4E17-A107-A2CD42B47F95Q34810602-B8D53EE8-9BC7-4CB4-884D-59E94EE28580Q35429605-275653FE-77BF-4C5A-89CC-3C76CAF3361DQ35604600-4258D9E7-01E9-40FB-9701-7EE561965FECQ35617966-4B31C366-EC70-4420-9266-E616971E5B89Q35764327-F4DAB52E-7DED-450D-BE77-79B00F4C825EQ35764977-3D994C6E-8449-4AF4-B0FB-999BF8980BEDQ35791732-37D324A9-4F1F-43D3-A9B0-0D9ED47D3ED4Q35823098-92A2A6D6-5FD8-41F3-A019-377AB2A2EB2FQ35901840-16F7481D-2307-4F0C-AE6F-E39E34196DF6Q36232769-7E296893-F00C-48A1-95DF-18B8B0C340EDQ36401755-D199BF8F-FB63-4AEC-B496-68FF406B0F94Q37066021-80EAB1DF-0ECA-4510-92B1-DCC0D987E2D0Q37078600-BE51626E-F8EF-4C62-A3AC-4CF6EE639D37Q37351869-E2ECC96F-19D8-4156-BECC-956932029831Q37372571-B0C3CDF2-A660-4575-B85A-8587AC0417EAQ37503726-1F322847-993E-4DEB-BC28-B0AC2F4A245BQ38164339-C831F8ED-6030-4A1C-A499-8ED3FBD8F63CQ39999171-FD10DD2A-82ED-4371-BF81-62628EB35042Q40240320-770187DA-8638-45DD-BBA1-BE7927CDF8ABQ40931728-AA56DCB1-B7A0-4C7E-9FFC-B0045AC7285EQ41064411-7CE9683B-C0BD-48D0-A1F4-C4C0DCE8B60DQ41083036-B78246A1-1DBF-4860-9E48-A5341D704604Q41311259-272003B7-E32D-4382-9B12-6204A7223BC3Q41877722-EA0C7769-54EB-47D3-B787-F76F09B32E24Q42158499-168A4CC7-39CB-446F-9C42-668C1BACD24AQ43000092-80722BE1-4D59-445E-B340-E706DCAC4544
P2860
The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
description
1991 nî lūn-bûn
@nan
1991 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
The ligand-binding domain of t ...... se-type plasminogen activator.
@ast
The ligand-binding domain of t ...... se-type plasminogen activator.
@en
The ligand-binding domain of t ...... se-type plasminogen activator.
@nl
type
label
The ligand-binding domain of t ...... se-type plasminogen activator.
@ast
The ligand-binding domain of t ...... se-type plasminogen activator.
@en
The ligand-binding domain of t ...... se-type plasminogen activator.
@nl
prefLabel
The ligand-binding domain of t ...... se-type plasminogen activator.
@ast
The ligand-binding domain of t ...... se-type plasminogen activator.
@en
The ligand-binding domain of t ...... se-type plasminogen activator.
@nl
P2093
P1476
The ligand-binding domain of t ...... se-type plasminogen activator.
@en
P2093
P304
P407
P577
1991-04-01T00:00:00Z